Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Zhejiang Cancer Hospital has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This suggests that the hospital's current patent interests are split between different technical specialties within the broader Biotechnology & Pharmaceuticals field. The use of 2 distinct art units for only 2 pending office actions highlights a lack of overlap in the subject matter currently under review.
KARUNASENA, ENUSHA is the busiest examiner, currently managing 1 pending office action. With 2 distinct examiners each handling the 2 pending office actions, the workload is balanced. This structure means that the hospital must manage separate prosecution tracks, each subject to the specific standards of different examiners and art units. The outcome of these 2 pending office actions will depend on the individual interpretations of KARUNASENA, ENUSHA and the other distinct examiner involved in the Biotechnology & Pharmaceuticals area.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KARUNASENA, ENUSHA | 1 | 0.0% | +0.0% |
| RIDDICK, BLAKE CUTLER | 1 | 78.2% | +9.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689866 | METHOD FOR RAPIDLY DETERMINING SURVIVAL CONDITION OF SPORES | KARUNASENA, ENUSHA | 14d |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 2884 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18689866 | METHOD FOR RAPIDLY DETERMINING SURVIVAL CONDITION OF SPORES | KARUNASENA, ENUSHA | 1653 | §102§103 | Non-Final OA | 14d | Pending | Mar 07, 2024 |
| 18689863 | METHOD AND FILM FOR MEASURING TWO-DIMENSIONAL DISTRIBUTION OF INDUSTRIAL IRRADIATION DOSE | RIDDICK, BLAKE CUTLER | 2884 | §103 | Final Rejection | 22d | Pending | Mar 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial